SecBot SecBot
SC 13G/A ·Filed Oct 30, 2026

RCKT

ROCKET PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2d 4h ago SEC0002100121-26-001123
Passive stake amendment
Actionable Insight • Neutral

This is a routine passive stake update by an index fund manager. No change in investment intent or strategy is indicated. Monitor for any future conversion to a 13D filing, which would signal an activist shift.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Vanguard Portfolio Management LLC filed an amended Schedule 13G disclosing a passive 1.33% stake in Rocket Pharmaceuticals as of September 30, 2026, representing 1,463,677 shares. This is a routine passive update by an index fund manager with no change in investment intent.

Key Financial Metrics

Stake
1.33%
Investor
Vanguard Portfolio Management LLC
Investor Type
index fund

Key Facts

  • Vanguard Portfolio Management LLC reported beneficial ownership of 1,463,677 shares of Rocket Pharmaceuticals common stock as of September 30, 2026.
  • The stake represents 1.33% of shares outstanding.
  • The filing is an amendment to a prior Schedule 13G, indicating a passive investment intent under Rule 13d-1(b).
  • Vanguard disclaims beneficial ownership of securities held by other affiliates and subsidiaries.
  • No single account's interest exceeds 5% of the reported securities.

Financial Impact

Stake valued at approximately $3.8 million based on market cap of $283M and 1.33% ownership.

Risk Factors

  • Passive filing, no material impact on stock price expected.
  • Vanguard's stake is small (1.33%) and unlikely to influence corporate governance.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
60% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0002100121-26-001123
Document: 0002100121-26-001123-index.html0002100121-26-001123
Document: 0002100121-26-001123.txt0002100121-26-001123
14 reports for RCKT
Performance horizon
80% Hit rate @ T+20 4 of 5 directional calls Went positive at some point 6 of 6 best @ T+20▲ +42.18%Jun 12, 2026
Filters
Rows
Reports for RCKT, sortable and filterable
TypeNow
Oct 30, 2026
2d ago
SC 13G/A
NEUTRAL ★ 2/10
$2.40awaiting T+20awaiting T+20$2.44 (+1.67%)
Oct 6, 2026
26d ago
8-K
BULLISH ★ 7/10
$2.54awaiting T+20awaiting T+20$2.44 (−3.75%)
Sep 15, 2026
6w ago
8-K
BULLISH ★ 7/10
$3.41 $2.30▼ −32.55%▼ −35.27%$2.44 (−28.45%)
Aug 20, 2026
10w ago
Insider Cluster
NEUTRAL ★ 4/10
$3.51 $3.27▼ −6.84%▼ −7.85%$2.44 (−30.48%)
Aug 17, 2026
10w ago
Insider Cluster
NEUTRAL ★ 4/10
$3.34 $3.49▲ +4.49%▲ +5.48%$2.44 (−26.95%)
Aug 13, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.47 $3.43▼ −1.15%▲ +0.84%$2.44 (−29.68%)
Aug 10, 2026
11w ago
8-K
BULLISH ★ 7/10
$3.50 $3.63▲ +3.71%▲ +4.77%$2.44 (−30.29%)
Aug 3, 2026
12w ago
8-K
BULLISH ★ 6/10
$3.41 $3.72▲ +9.09%▲ +7.85%$2.44 (−28.45%)
Jun 30, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$3.52 $3.14▼ −10.80%▼ −8.61%$2.44 (−30.68%)
Jun 12, 2026
20w ago
8-K
BULLISH ★ 5/10
$2.75 $3.91▲ +42.18%▲ +40.40%$2.44 (−11.27%)
Showing 10 of 14

US Market Status

Market Closed · Opens Mon (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026